Quidel | QDEL - Current Assets


Quidel reported $1.45B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Abbott USD 26B 1.16B Dec/2025
Agilent USD 4.59B 341M Sep/2025
Avanos Medical USD 351.4M 4.6M Sep/2025
Becton, Dickinson and Co. USD 9.19B 66M Dec/2025
Bruker USD 2.21B 138.1M Dec/2025
Cerus USD 167.13M 1.41M Sep/2025
Charles River Laboratories USD 1.45B 85.06M Dec/2025
Danaher USD 12.76B 3.15B Dec/2025
Exact Sciences USD 1.56B 34.88M Dec/2025
Haemonetics USD 943.67M 43.99M Dec/2025
Hologic USD 3.84B 175.3M Dec/2025
Illumina USD 3.29B 493M Dec/2025
IQVIA Holdings USD 6.25B 270M Dec/2025
Merit Medical Systems USD 985.53M 62.46M Sep/2025
Mettler Toledo International USD 1.36B 81.46M Dec/2025
Myriad Genetics USD 344.8M 60.5M Sep/2025
Neogen USD 574.58M 50.52M Sep/2025
OraSure Technologies USD 283.01M 18.43M Sep/2025
Pacific Biosciences Of California USD 394.24M 19.16M Sep/2025
Quidel USD 1.45B 80.6M Dec/2025
Revvity USD 2.24B 95.96M Dec/2025
STAAR Surgical USD 321.21M 28.42M Sep/2025
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025
Waters USD 1.99B 69.86M Dec/2025